Rv1630 - p.Ala344Val
Drug resistance types
2 Sensitive
4 RR-TB
3 HR-TB
10 MDR-TB
0 Pre-XDR-TB
0 XDR-TB
7 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.9 | 7 |
| lineage4.9;lineage7 | 3 |
| La1.4 | 1 |
| lineage2.2.1 | 2 |
| lineage4.2.2.2 | 1 |
| lineage3 | 2 |
| lineage4.3.4.2.1 | 1 |
| lineage4.4.1.1.1 | 2 |
| lineage2;lineage4 | 1 |
| lineage2.1;lineage4.9;lineage7 | 1 |
| lineage4.8.1 | 2 |
| lineage4.3.3 | 1 |
| lineage2.1;lineage4.9 | 1 |
| lineage4.1.1.1 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 26 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR3675582 | Other | lineage4.9 | None | SRR3675456 | RR-TB | lineage4.9;lineage7 | None | SRR16278274 | Other | La1.4 | None | SRR3675539 | HR-TB | lineage4.9;lineage7 | None | SRR6046382 | Sensitive | lineage2.2.1 | None | SRR11342687 | RR-TB | lineage4.2.2.2 | None | ERR2446509 | Other | lineage3 | nl | SRR5818647 | Other | lineage4.3.4.2.1 | None | SRR3675280 | RR-TB | lineage4.9 | None | ERR3283021 | HR-TB | lineage4.9 | None | SRR11342696 | MDR-TB | lineage4.4.1.1.1 | None | ERR3797047 | MDR-TB | lineage4.9 | None | ERR1023502 | MDR-TB | lineage2;lineage4 | None | SRR3675555 | HR-TB | lineage2.1;lineage4.9;lineage7 | None | ERR3275190 | Other | lineage3 | nl | SRR11342662 | MDR-TB | lineage4.8.1 | None | SRR11342649 | MDR-TB | lineage4.3.3 | None | SRR3675284 | Sensitive | lineage4.9 | None | SRR3675231 | MDR-TB | lineage4.9;lineage7 | None | SRR11342660 | MDR-TB | lineage2.2.1 | None | SRR11342644 | MDR-TB | lineage4.4.1.1.1 | None | SRR11342693 | MDR-TB | lineage4.8.1 | None | ERR387051 | Other | lineage4.9 | None | SRR1735596 | RR-TB | lineage4.9 | None | SRR3675495 | Other | lineage2.1;lineage4.9 | None | SRR11342642 | MDR-TB | lineage4.1.1.1 | None |
|---|
